数据口径(与 Hub / TREND_SUMMARY 一致):
papers_meta 2511 篇全 ok;有代码仓 1584(63.1%);
年份 2025=1142 · 2026=1369;会场 127。热词为标题英文粗分词(去停用词),仅作趋势嗅探,非严格 NLP。
LREC / SMM4H 等在 2026 有集中收录,2025 侧为 0 不代表会议未开,而是本库纳入范围差异。
2025→2026 抬头热词(相对上升)
| term | 2025 | 2026 | Δrate |
|---|---|---|---|
| reasoning | 69 | 153 | +0.0513 |
| smm4h-heard | 0 | 37 | +0.0270 |
| agentic | 8 | 39 | +0.0215 |
| evidence | 7 | 33 | +0.0180 |
| segmentation | 10 | 32 | +0.0146 |
| classification | 16 | 39 | +0.0145 |
| pipeline | 3 | 22 | +0.0134 |
| biomedical | 50 | 78 | +0.0132 |
| benchmarking | 20 | 42 | +0.0132 |
| multi-agent | 23 | 45 | +0.0127 |
| reinforcement | 9 | 28 | +0.0126 |
| diagnostic | 5 | 22 | +0.0117 |
| psydefdetect | 0 | 16 | +0.0117 |
| benchmark | 47 | 72 | +0.0114 |
| nlp | 4 | 20 | +0.0111 |
| dynamic | 10 | 27 | +0.0110 |
| structured | 16 | 34 | +0.0108 |
| modeling | 15 | 32 | +0.0102 |
| efficient | 10 | 26 | +0.0102 |
| defense | 0 | 14 | +0.0102 |
2025→2026 回落热词(相对下降)
| term | 2025 | 2026 | Δrate |
|---|---|---|---|
| summarization | 41 | 17 | -0.0235 |
| knowledge | 70 | 52 | -0.0233 |
| task | 43 | 23 | -0.0209 |
| enhancing | 42 | 22 | -0.0207 |
| domain | 30 | 15 | -0.0153 |
| through | 39 | 26 | -0.0152 |
| leveraging | 19 | 5 | -0.0130 |
| chinese | 21 | 8 | -0.0125 |
| foundation | 34 | 25 | -0.0115 |
| peranssumm | 13 | 0 | -0.0114 |
| protein | 23 | 12 | -0.0114 |
| survey | 14 | 2 | -0.0108 |
| representation | 20 | 10 | -0.0102 |
| generation | 119 | 129 | -0.0100 |
| semeval-2025 | 11 | 0 | -0.0096 |
| rag | 18 | 9 | -0.0092 |
| lay | 12 | 2 | -0.0090 |
| retrieval-augmented | 33 | 28 | -0.0084 |
| shared | 22 | 15 | -0.0083 |
| human | 16 | 8 | -0.0082 |
各年标题热词 Top15
2025 Top15
| # | term | count |
|---|---|---|
| 1 | generation | 119 |
| 2 | knowledge | 70 |
| 3 | reasoning | 69 |
| 4 | vision-language | 62 |
| 5 | detection | 58 |
| 6 | question | 55 |
| 7 | answering | 52 |
| 8 | evaluation | 50 |
| 9 | biomedical | 50 |
| 10 | benchmark | 47 |
| 11 | report | 46 |
| 12 | alignment | 44 |
| 13 | task | 43 |
| 14 | enhancing | 42 |
| 15 | summarization | 41 |
2026 Top15
| # | term | count |
|---|---|---|
| 1 | reasoning | 153 |
| 2 | generation | 129 |
| 3 | biomedical | 78 |
| 4 | detection | 75 |
| 5 | benchmark | 72 |
| 6 | vision-language | 70 |
| 7 | report | 68 |
| 8 | evaluation | 61 |
| 9 | question | 57 |
| 10 | extraction | 56 |
| 11 | answering | 53 |
| 12 | knowledge | 52 |
| 13 | retrieval | 48 |
| 14 | diagnosis | 46 |
| 15 | evaluating | 46 |
会场 × 年份(Top15 会场,可读热力表)
| year | ACL | Findings-ACL | BioNLP | MICCAI | AAAI | ICLR | EMNLP | NeurIPS | Findings-EMNLP | CL4HEALTH | ICML | LREC | SMM4H | ClinicalNLP | CVPR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 93 | 71 | 68 | 74 | 58 | 76 | 115 | 63 | 68 | 42 | 35 | 0 | 0 | 11 | 17 |
| 2026 | 151 | 127 | 123 | 94 | 110 | 82 | 42 | 48 | 32 | 51 | 36 | 60 | 53 | 41 | 35 |
会场增量解读(按 |Δ| 排序)
| venue | 2025 | 2026 | Δ(2026−2025) |
|---|---|---|---|
| EMNLP | 115 | 42 | -73 |
| LREC | 0 | 60 | +60 |
| ACL | 93 | 151 | +58 |
| Findings-ACL | 71 | 127 | +56 |
| BioNLP | 68 | 123 | +55 |
| SMM4H | 0 | 53 | +53 |
| AAAI | 58 | 110 | +52 |
| Findings-EMNLP | 68 | 32 | -36 |
| ClinicalNLP | 11 | 41 | +30 |
| MICCAI | 74 | 94 | +20 |
| CVPR | 17 | 35 | +18 |
| NeurIPS | 63 | 48 | -15 |
| CL4HEALTH | 42 | 51 | +9 |
| ICLR | 76 | 82 | +6 |
| ICML | 35 | 36 | +1 |
2026 相对增幅(篇)
- LREC:0 → 60(+60)
- ACL:93 → 151(+58)
- Findings-ACL:71 → 127(+56)
- BioNLP:68 → 123(+55)
- SMM4H:0 → 53(+53)
- AAAI:58 → 110(+52)
2026 相对减幅(篇)
- EMNLP:115 → 42(−73)
- Findings-EMNLP:68 → 32(−36)
- NeurIPS:63 → 48(−15)
- NAACL / COLING 等在本库 2025 侧更厚(会议周期与纳入批次)
会场 × 有仓率
按篇数 Top20
| venue | n | 有仓 | 有仓率 |
|---|---|---|---|
| ACL | 244 | 165 | 67.6% |
| Findings-ACL | 198 | 143 | 72.2% |
| BioNLP | 191 | 104 | 54.5% |
| MICCAI | 168 | 131 | 78.0% |
| AAAI | 168 | 93 | 55.4% |
| ICLR | 158 | 131 | 82.9% |
| EMNLP | 157 | 103 | 65.6% |
| NeurIPS | 111 | 65 | 58.6% |
| Findings-EMNLP | 100 | 74 | 74.0% |
| CL4HEALTH | 93 | 56 | 60.2% |
| ICML | 71 | 49 | 69.0% |
| LREC | 60 | 42 | 70.0% |
| SMM4H | 53 | 20 | 37.7% |
| ClinicalNLP | 52 | 21 | 40.4% |
| CVPR | 52 | 30 | 57.7% |
| EACL | 51 | 38 | 74.5% |
| CLPSYCH | 45 | 15 | 33.3% |
| IJCAI | 42 | 24 | 57.1% |
| NAACL | 41 | 28 | 68.3% |
| COLING | 33 | 24 | 72.7% |
有仓率高(n≥50)
| venue | n | 有仓 | 有仓率 |
|---|---|---|---|
| ICLR | 158 | 131 | 82.9% |
| MICCAI | 168 | 131 | 78.0% |
| EACL | 51 | 38 | 74.5% |
| Findings-EMNLP | 100 | 74 | 74.0% |
| Findings-ACL | 198 | 143 | 72.2% |
| LREC | 60 | 42 | 70.0% |
| ICML | 71 | 49 | 69.0% |
| ACL | 244 | 165 | 67.6% |
| EMNLP | 157 | 103 | 65.6% |
| CL4HEALTH | 93 | 56 | 60.2% |
| NeurIPS | 111 | 65 | 58.6% |
| CVPR | 52 | 30 | 57.7% |
有仓率偏低(n≥40)
| venue | n | 有仓 | 有仓率 |
|---|---|---|---|
| CLPSYCH | 45 | 15 | 33.3% |
| SMM4H | 53 | 20 | 37.7% |
| ClinicalNLP | 52 | 21 | 40.4% |
| BioNLP | 191 | 104 | 54.5% |
| AAAI | 168 | 93 | 55.4% |
| IJCAI | 42 | 24 | 57.1% |
| CVPR | 52 | 30 | 57.7% |
| NeurIPS | 111 | 65 | 58.6% |
源文件与相关页
- TREND_SUMMARY_zh.md — 趋势结论速览
- year_title_hotwords.md — 热词完整 Top40 + 升降
- year_venue_heatmap.md — year×venue Top25
- venue_code_stats.csv — 会场有仓率全表
- Hub / index · SUMMARY_HUB · 产物目录